Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
Nicola Clementi, Carolina Scagnolari, Antonella D’Amore, Fioretta Palombi, Elena Criscuolo, Federica Frasca, Alessandra Pierangeli, Nicasio Mancini, Guido Antonelli, Massimo Clementi, Armando Carpaneto, Antonio Filippini
Topics & Concepts
NaringeninIn vitroSchematicDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyCoronavirus disease 2019 (COVID-19)VirologyChemistryBiologyMicrobiologyMedicineBiochemistryInternal medicineFlavonoidEngineeringInfectious disease (medical specialty)Electronic engineeringAntioxidantDiseaseCalcium signaling and nucleotide metabolismPARP inhibition in cancer therapySirtuins and Resveratrol in Medicine